| Primary |
| Hepatitis C |
56.5% |
| Malignant Melanoma |
8.7% |
| Multiple Myeloma |
7.6% |
| Multiple Sclerosis |
6.5% |
| Hepatitis |
3.3% |
| Mycosis Fungoides |
2.2% |
| Off Label Use |
2.2% |
| Anaemia |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Chronic Hepatitis C |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Fibromyalgia |
1.1% |
| Hepatitis B |
1.1% |
| Liver Transplant |
1.1% |
| Lung Neoplasm Malignant |
1.1% |
| Mammoplasty |
1.1% |
| Melanoma Recurrent |
1.1% |
| Metastatic Malignant Melanoma |
1.1% |
| Urinary Tract Infection |
1.1% |
|
| Death |
8.3% |
| Depression |
8.3% |
| Hepatitis C |
8.3% |
| Systemic Inflammatory Response Syndrome |
8.3% |
| Thrombocytopenia |
8.3% |
| Weight Decreased |
8.3% |
| Blood Creatine Phosphokinase Increased |
5.6% |
| Pancytopenia |
5.6% |
| Suicidal Ideation |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Anaemia |
2.8% |
| Anaemia Haemolytic Autoimmune |
2.8% |
| Breast Infection |
2.8% |
| Cognitive Disorder |
2.8% |
| Delirium |
2.8% |
| Diabetic Coma |
2.8% |
| Encephalopathy |
2.8% |
| Haemorrhage |
2.8% |
| Headache |
2.8% |
| Hepatocellular Carcinoma |
2.8% |
|
| Secondary |
| Hepatitis C |
61.8% |
| Product Used For Unknown Indication |
9.0% |
| Chronic Myeloid Leukaemia |
4.9% |
| Multiple Myeloma |
4.8% |
| Hiv Infection |
2.1% |
| Metastatic Renal Cell Carcinoma |
2.0% |
| Chronic Hepatitis C |
1.9% |
| Renal Cell Carcinoma |
1.5% |
| Bladder Cancer |
1.4% |
| Ovarian Cancer |
1.3% |
| Drug Use For Unknown Indication |
1.2% |
| Acute Myeloid Leukaemia |
1.1% |
| Hypertension |
1.1% |
| Anaesthesia Procedure |
1.0% |
| Schizophrenia |
1.0% |
| Depression |
0.8% |
| Essential Thrombocythaemia |
0.8% |
| Myelodysplastic Syndrome |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Polycythaemia Vera |
0.7% |
|
| White Blood Cell Count Decreased |
12.6% |
| Rash |
10.8% |
| Vomiting |
10.4% |
| Neoplasm Malignant |
9.1% |
| Off Label Use |
5.2% |
| Pyrexia |
4.3% |
| Weight Decreased |
4.3% |
| Death |
3.9% |
| Pancytopenia |
3.9% |
| Rash Generalised |
3.9% |
| Weight Increased |
3.9% |
| Anaemia |
3.5% |
| Drug Ineffective |
3.5% |
| Neutropenia |
3.5% |
| Renal Impairment |
3.5% |
| Hepatitis C |
3.0% |
| Thrombosis |
3.0% |
| Pruritus |
2.6% |
| Syncope |
2.6% |
| Thrombocytopenia |
2.6% |
|
| Concomitant |
| Hepatitis C |
37.2% |
| Multiple Myeloma |
11.4% |
| Product Used For Unknown Indication |
8.5% |
| Hiv Infection |
6.6% |
| Drug Use For Unknown Indication |
5.5% |
| Hypertension |
4.4% |
| Anaemia |
3.7% |
| Pain |
3.6% |
| Depression |
2.6% |
| Hepatitis B |
2.2% |
| Schizophrenia |
1.8% |
| Anxiety |
1.7% |
| Chronic Myeloid Leukaemia |
1.7% |
| Renal Cell Carcinoma |
1.6% |
| Multiple Sclerosis |
1.5% |
| Metastases To Bone |
1.3% |
| Asthma |
1.2% |
| Imaging Procedure |
1.2% |
| Pre-existing Disease |
1.0% |
| Plasma Cell Myeloma |
1.0% |
|
| Vomiting |
11.5% |
| White Blood Cell Count Decreased |
11.5% |
| Rash |
10.6% |
| Weight Decreased |
5.9% |
| Wound Infection |
5.9% |
| Anaemia |
4.7% |
| Aplasia Pure Red Cell |
4.7% |
| X-ray Abnormal |
4.5% |
| Pain |
4.0% |
| Varices Oesophageal |
4.0% |
| Platelet Count Decreased |
3.8% |
| Pyrexia |
3.8% |
| Pruritus |
3.4% |
| Therapeutic Response Decreased |
3.4% |
| Tooth Extraction |
3.4% |
| Hepatitis C |
3.2% |
| Nausea |
3.0% |
| Thrombocytopenia |
3.0% |
| Visual Acuity Reduced |
3.0% |
| Haemoglobin Decreased |
2.8% |
|
| Interacting |
| Multiple Sclerosis |
40.0% |
| Hepatitis C |
30.0% |
| Hepatitis B |
15.0% |
| Liver Transplant |
10.0% |
| Schizophrenia |
5.0% |
|
| Hallucination, Visual |
40.0% |
| Drug Interaction |
20.0% |
| Fatigue |
20.0% |
| Haematocrit Decreased |
10.0% |
| White Blood Cell Count Decreased |
10.0% |
|
